NGGT-002

DB17881InvestigationalGene Therapies

NGGT-002 is a recombinant adeno-associated virus serotype 8 vector encoding human phenylalanine hydroxylase (PAH).

Code names
NGGT-002

What you can answer from here — as of September 25, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of NGGT-002, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In